Press release
Rising Prevalence Of Infectious Diseases Fuels Peptide Antibiotics Market: Key Factor Driving The Growth In The Peptide Antibiotics Market
Peptide Antibiotics
What Is the Expected Peptide Antibiotics Market Size During the Forecast Period?
In recent times, the market size for peptide antibiotics has experienced a surge and its size is projected to elevate from $5.25 billion in 2024 to $5.82 billion by 2025, growing at a Compound Annual Growth Rate (CAGR) of 10.8%. The expansion throughout the previous period is a result of studies and development of peptide antibiotics, an enhancement in antibiotic resistance, an uplift in the prevalence of infectious diseases, advancements in peptide synthesis technologies, and the expansion of the pharmaceutical industry.
In the coming years, the peptide antibiotics market is predicted to experience robust growth. This market is projected to reach $8.47 billion by the year 2029, growing at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth during the forecast period could be due to a focus on the development of new antibiotics, a rise in antibiotic-resistant infections globally, enhancement of research and development in antimicrobial peptides, and regulatory backing for new antibiotic approvals. The forecast period is expected to witness major trends like the exploration of natural sources for antimicrobial peptides, the use of peptide antibiotics in animal healthcare, emphasis on peptide engineering for increasing efficaciousness, the development of combination peptide antibiotics, and the application of artificial intelligence and machine learning in peptide antibiotic discovery.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780
What Are the High-Growth Segments in the Peptide Antibiotics Market?
The peptide antibiotics market covered in this report is segmented -
1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels
Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp
What Key Drivers Are Expected to Influence Future Peptide Antibiotics Market Growth?
The prevalence of various infectious diseases is on the rise, which is expected to fuel the growth of the peptide antibiotics market. These diseases are brought on by hazardous micro-organisms like bacteria, fungi, parasites, among others. The increase in infectious diseases is majorly due to factors such as rapid urbanization, climate changes, and an escalated risk of emergent diseases, all contributing to the growing need for peptide antibiotics. These antibiotics work by breaking down the cell membranes, reinforcing their antibacterial action. To illustrate, in May 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that in the America region, dengue cases had already exceeded seven million by April 2024, a stark increase from the 4.6 million cases reported for the entire 2023. Consequently, the rising rate of infectious diseases is driving the growth of the peptide antibiotics market.
Which Companies Hold the Largest Share Across Different Peptide Antibiotics Market Segments?
Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG
What Trends Are Driving Growth in The Peptide Antibiotics Market?
The peptide antibiotics market is witnessing a growing trend of strategic collaborations among major players. These partnerships aim to broaden their market reach and mutually benefit from each other's resources. Such an example is the collaboration between Berkeley Lights, an American digital cell biology firm, and Aanika Biosciences in January 2022. Aanika Biosciences plans to utilize Berkeley Lights' efficient and high-throughput screening services to quickly locate and improve functional antimicrobial peptides (AMPs), focused on eradicating harmful bacteria, particularly those implicated in foodborne illnesses. Additionally, the Beacon Optofluidic Platform will be employed to detect peptides detrimental to bacteria for developing an innovative antibacterial tag. This tag will then be integrated into their bacterial spore-based barcoding technology aimed at safeguarding the food supply chain. Aanika Biosciences is a biotech firm based in the USA.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report
What Are the Emerging Geographies for The Peptide Antibiotics Market Growth?
North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Peptide Antibiotics Market?
2. What is the CAGR expected in the Peptide Antibiotics Market?
3. What Are the Key Innovations Transforming the Peptide Antibiotics Industry?
4. Which Region Is Leading the Peptide Antibiotics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Infectious Diseases Fuels Peptide Antibiotics Market: Key Factor Driving The Growth In The Peptide Antibiotics Market here
News-ID: 3961936 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
